Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes

被引:70
作者
Klein, George [1 ]
Klein, Eva [1 ]
Kashuba, Elena [1 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden
关键词
Epstein-Barr virus; Cell transformation; Burkitt lymphoma; EBNA; Apoptosis; Protein-protein interaction; Cell cycle control; NUCLEAR ANTIGEN 3C; PROTEIN EBNA-3 BINDS; ENCODED EBNA-5; DNA-BINDING; J-KAPPA; TRANSCRIPTIONAL ACTIVATION; NUCLEOLAR TRANSLOCATION; HISTONE DEACETYLASE; GENE-EXPRESSION; CELLS;
D O I
10.1016/j.bbrc.2010.02.146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epstein-Barr virus, EBV, and humans have a common history that reaches back to our primate ancestors. The virus co-evolved with man and has established a largely harmless and highly complex co-existence. It is carried as silent infection by almost all human adults. A serendipitous discovery established that it is the causative agent of infectious mononucleosis. Still, EBV became known first in 1964, in a rare, geographically prevalent malignant lymphoma of B-cell origin, Burkitt lymphoma BL Its association with a malignancy prompted intensive studies and its capacity to immortalize B-lymphocytes in vitro was soon demonstrated. Consequently EBV was classified therefore as a potentially tumorigenic virus. Despite of this property however, the virus carrier state itself does not lead to malignancies because the transformed cells are recognized by the immune response. Consequently the EBV induced proliferation of EBV carrying B-lymphocytes is manifested only under immunosuppressive conditions. The expression of EBV encoded genes is regulated by the cell phenotype. The virus genome can be found in malignancies originating from cell types other than the B-lymphocyte. Even in the EBV infected B-cell, the direct transforming capacity is restricted to a defined window of differentiation. A complex interaction between virally encoded proteins and B-cell specific cellular proteins constitute the proliferation inducing program. In this short review we touch upon aspects which are the subject of our present work. We describe the mechanisms of some of the functional interactions between EBV encoded and cellular proteins that determine the phenotype of latently infected B-cells. The growth promoting EBV encoded genes are not expressed in the virus carrying BL cells. Still, EBV seems to contribute to the etiology of this tumor by modifying events that influence cell survival and proliferation. We describe a possible growth promoting mechanism in the genesis of Burkitt lymphoma that depends on the presence of EBV. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 100 条
[41]   IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter [J].
Kis, Lorand L. ;
Salamon, Daniel ;
Persson, Emma K. ;
Nagy, Noemi ;
Scheeren, Ferenc A. ;
Spits, Hergen ;
Klein, George ;
Klein, Eva .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (02) :872-877
[42]  
KLEIN E, 2009, SEMIN CANC BIOL, V19
[43]   Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase [J].
Knight, JS ;
Sharma, N ;
Robertson, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) :18562-18566
[44]   SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen [J].
Knight, JS ;
Sharma, N ;
Robertson, ES .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (05) :1749-1763
[45]   Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity [J].
Knight, JS ;
Robertson, ES .
JOURNAL OF VIROLOGY, 2004, 78 (04) :1981-1991
[46]   Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines [J].
Knight, JS ;
Lan, K ;
Subramanian, C ;
Robertson, ES .
JOURNAL OF VIROLOGY, 2003, 77 (07) :4261-4272
[47]   Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata [J].
Komano, J ;
Sugiura, M ;
Takada, K .
JOURNAL OF VIROLOGY, 1998, 72 (11) :9150-9156
[48]   The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein [J].
Krauer, KG ;
Buck, M ;
Belzer, DK ;
Flanagan, J ;
Chojnowski, GM ;
Sculley, TB .
VIROLOGY, 2004, 318 (01) :280-294
[49]   The EBNA-3 gene family proteins disrupt the G2/M checkpoint [J].
Krauer, KG ;
Burgess, A ;
Buck, M ;
Flanagan, J ;
Gabrielli, B .
ONCOGENE, 2004, 23 (07) :1342-1353
[50]   Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes [J].
Krauer, KG ;
Kienzle, N ;
Young, DB ;
Sculley, TB .
VIROLOGY, 1996, 226 (02) :346-353